← FDA DRUG APPROVALS
FDA NDA · NDA020870
COMBIPATCH (ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM)
estradiol/norethindrone acetate transdermal system
Sponsor: NOVEN PHARMS INC
APPLICATION
NDA020870
TYPE
NDA
ORIGINAL APPROVAL
1998-08-07
LATEST ACTION
2024-02-15
ROUTE
TRANSDERMAL
DOSAGE FORM
FILM, EXTENDED RELEASE
MARKETING STATUS
Prescription
Products
COMBIPATCH · ReferencePrescription
ESTRADIOL 0.05MG/24HR, NORETHINDRONE ACETATE 0.14MG/24HR · FILM, EXTENDED RELEASE · TRANSDERMAL
COMBIPATCH · ReferencePrescription
ESTRADIOL 0.05MG/24HR, NORETHINDRONE ACETATE 0.25MG/24HR · FILM, EXTENDED RELEASE · TRANSDERMAL
Approval history
2015-06-08Manufacturing (CMC) · Supplement 20 · standardAP
2002-04-01Manufacturing (CMC) · Supplement 7 · standardAP
2002-02-12Manufacturing (CMC) · Supplement 8 · standardAP
2001-03-15Manufacturing (CMC) · Supplement 5 · standardAP
2000-05-04Manufacturing (CMC) · Supplement 4 · standardAP
2000-04-19Manufacturing (CMC) · Supplement 3 · standardAP
2000-02-04Manufacturing (CMC) · Supplement 2 · standardAP
1999-11-29Manufacturing (CMC) · Supplement 1 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.